Modern medicine is making progress in how we can treat severe injuries, but even with today's technology, there are limits to how we can help heal wounded patients.
StemSys® was founded in an effort to overcome limitations of tissue devices developed to date and help heal even the most severely injured.
Wound healing and tissue regeneration is a complex multi-stage process. Injured or damaged tissue requires multiple biomolecules to facilitate healing at the site of injury. Biomolecules have been identified in Extracellular matrix (ECM), including fibrous proteins such as different collagen types, elastin, fibronectin, and laminin. ECM also may comprise glycosaminoglycans (GAGs) such as heparin sulfate, and various growth factors.
ECMs are not created equally. They have different biomolecules for different tissues. After years of researching various tissues, StemSys identified (or discovered??) which ECMs have the highest amounts of biomolecules needed for site-specific healing.
Not limited to the biomolecules of one tissue source. StemSys combines multiple tissues and makes a custom blend of powder to provide the body access with higher amounts of biomolecues to facilitate healing.